Cargando…

Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains

BACKGROUND: Different strains of the genus Bacillus are versatile candidates for the industrial production and secretion of heterologous proteins. They can be cultivated quite easily, show high growth rates and are usually non-pathogenic and free of endo- and exotoxins. They have the ability to secr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakowitz, Antonia, Krull, Rainer, Biedendieck, Rebekka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259949/
https://www.ncbi.nlm.nih.gov/pubmed/28115011
http://dx.doi.org/10.1186/s12934-017-0625-9
_version_ 1782499309853343744
author Lakowitz, Antonia
Krull, Rainer
Biedendieck, Rebekka
author_facet Lakowitz, Antonia
Krull, Rainer
Biedendieck, Rebekka
author_sort Lakowitz, Antonia
collection PubMed
description BACKGROUND: Different strains of the genus Bacillus are versatile candidates for the industrial production and secretion of heterologous proteins. They can be cultivated quite easily, show high growth rates and are usually non-pathogenic and free of endo- and exotoxins. They have the ability to secrete proteins with high efficiency into the growth medium, which allows cost-effective downstream purification processing. Some of the most interesting and challenging heterologous proteins are recombinant antibodies and antibody fragments. They are important and suitable tools in medical research for analytics, diagnostics and therapy. The smallest conventional antibody fragment with high-affinity binding to an antigen is the single-chain fragment variable (scFv). Here, different strains of the genus Bacillus were investigated using diverse cultivation systems for their suitability to produce and secret a recombinant scFv. RESULTS: Extracellular production of lysozyme-specific scFv D1.3 was realized by constructing a plasmid with a xylose-inducible promoter optimized for Bacillus megaterium and the D1.3scFv gene fused to the coding sequence of the LipA signal peptide from B. megaterium. Functional scFv was successfully secreted with B. megaterium MS941, Bacillus licheniformis MW3 and the three Bacillus subtilis strains 168, DB431 and WB800N differing in the number of produced proteases. Starting with shake flasks (150 mL), the bioprocess was scaled down to microtiter plates (1250 µL) as well as scaled up to laboratory-scale bioreactors (2 L). The highest extracellular concentration of D1.3 scFv (130 mg L(−1)) and highest space–time-yield (8 mg L(−1) h(−1)) were accomplished with B. subtilis WB800N, a strain deficient in eight proteases. These results were reproduced by the production and secretion of a recombinant penicillin G acylase (Pac). CONCLUSIONS: The genus Bacillus provides high potential microbial host systems for the secretion of challenging heterologous proteins like antibody fragments and large proteins at high titers. In this study, the highest extracellular concentration and space–time-yield of a recombinant antibody fragment for a Gram-positive bacterium so far was achieved. The successful interspecies use of the here-designed plasmid originally optimized for B. megaterium was demonstrated by two examples, an antibody fragment and a penicillin G acylase in up to five different Bacillus strains. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-017-0625-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5259949
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52599492017-01-26 Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains Lakowitz, Antonia Krull, Rainer Biedendieck, Rebekka Microb Cell Fact Research BACKGROUND: Different strains of the genus Bacillus are versatile candidates for the industrial production and secretion of heterologous proteins. They can be cultivated quite easily, show high growth rates and are usually non-pathogenic and free of endo- and exotoxins. They have the ability to secrete proteins with high efficiency into the growth medium, which allows cost-effective downstream purification processing. Some of the most interesting and challenging heterologous proteins are recombinant antibodies and antibody fragments. They are important and suitable tools in medical research for analytics, diagnostics and therapy. The smallest conventional antibody fragment with high-affinity binding to an antigen is the single-chain fragment variable (scFv). Here, different strains of the genus Bacillus were investigated using diverse cultivation systems for their suitability to produce and secret a recombinant scFv. RESULTS: Extracellular production of lysozyme-specific scFv D1.3 was realized by constructing a plasmid with a xylose-inducible promoter optimized for Bacillus megaterium and the D1.3scFv gene fused to the coding sequence of the LipA signal peptide from B. megaterium. Functional scFv was successfully secreted with B. megaterium MS941, Bacillus licheniformis MW3 and the three Bacillus subtilis strains 168, DB431 and WB800N differing in the number of produced proteases. Starting with shake flasks (150 mL), the bioprocess was scaled down to microtiter plates (1250 µL) as well as scaled up to laboratory-scale bioreactors (2 L). The highest extracellular concentration of D1.3 scFv (130 mg L(−1)) and highest space–time-yield (8 mg L(−1) h(−1)) were accomplished with B. subtilis WB800N, a strain deficient in eight proteases. These results were reproduced by the production and secretion of a recombinant penicillin G acylase (Pac). CONCLUSIONS: The genus Bacillus provides high potential microbial host systems for the secretion of challenging heterologous proteins like antibody fragments and large proteins at high titers. In this study, the highest extracellular concentration and space–time-yield of a recombinant antibody fragment for a Gram-positive bacterium so far was achieved. The successful interspecies use of the here-designed plasmid originally optimized for B. megaterium was demonstrated by two examples, an antibody fragment and a penicillin G acylase in up to five different Bacillus strains. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-017-0625-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-23 /pmc/articles/PMC5259949/ /pubmed/28115011 http://dx.doi.org/10.1186/s12934-017-0625-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lakowitz, Antonia
Krull, Rainer
Biedendieck, Rebekka
Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains
title Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains
title_full Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains
title_fullStr Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains
title_full_unstemmed Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains
title_short Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains
title_sort recombinant production of the antibody fragment d1.3 scfv with different bacillus strains
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259949/
https://www.ncbi.nlm.nih.gov/pubmed/28115011
http://dx.doi.org/10.1186/s12934-017-0625-9
work_keys_str_mv AT lakowitzantonia recombinantproductionoftheantibodyfragmentd13scfvwithdifferentbacillusstrains
AT krullrainer recombinantproductionoftheantibodyfragmentd13scfvwithdifferentbacillusstrains
AT biedendieckrebekka recombinantproductionoftheantibodyfragmentd13scfvwithdifferentbacillusstrains